CELF5 Inhibitors

Chemical inhibitors of CELF5 operate through various mechanisms to impede its function in RNA processing. Leptomycin B, for instance, targets exportin 1 (CRM1), a key protein in the nuclear export pathway. By inhibiting CRM1, Leptomycin B can cause the nuclear retention of CELF5, thereby preventing it from carrying out its typical roles in the cytoplasm. Similarly, Mitoxantrone, through its intercalation with DNA and inhibition of topoisomerase II, disrupts DNA synthesis and repair. This alteration in the nuclear environment can indirectly affect CELF5 by modifying post-transcriptional control mechanisms that require CELF5 activity. Another inhibitor, Alpha-amanitin, directly inhibits RNA polymerase II, crucial for mRNA synthesis, thereby reducing the availability of RNA substrates for CELF5, which in turn affects CELF5's RNA binding and processing activities. Actinomycin D also binds to DNA but does so at the transcription initiation complex, which prevents RNA chain elongation by RNA polymerase, resulting in a reduction in the RNA substrates needed for CELF5 function.

Further down the line of transcription-related inhibitors, DRB and Flavopiridol inhibit RNA polymerase II-mediated transcription, which can decrease the transcription of RNAs that CELF5 is meant to bind and regulate, thus inhibiting its function. Camptothecin and Etoposide, both topoisomerase inhibitors, cause DNA damage, which can disrupt transcription processes and subsequently hinder CELF5's interaction with RNA transcripts. Triptolide's broad inhibition of RNA polymerases I, II, and III and Aphidicolin's selective inhibition of DNA polymerases alpha and delta both lead to a general decrease in RNA synthesis, affecting the pool of RNA molecules available for CELF5 to act upon. Cordycepin, due to its structural similarity to adenosine, acts as a chain terminator during RNA synthesis, which reduces the length and quantity of RNA transcripts for CELF5 binding and regulation. Lastly, ICRF-193's stabilization of the topoisomerase II cleavable complex results in transcriptional inhibition, which can indirectly inhibit CELF5 by interfering with the maturation of RNA transcripts CELF5 typically regulates.